Cidara Therapeutics Inc. (CDTX) NASDAQ
$0.88 0.04 (4.35%)
Market Cap: $76.31M
As of 03/28/24 09:44 AM EDT. Market open.
Cidara Therapeutics Inc. (CDTX)
NASDAQ
$0.88
0.04 (4.35%)
Market Cap: $76.31M
As of 03/28/24 09:44 AM EDT. Market open.
cidara is a biotechnology company focused on the discovery, development, and commercialization of novel anti-infectives for the treatment of diseases that are inadequately addressed by current standard of care therapies. our first product candidate is cd101 iv, a potential once-weekly intravenous therapy being developed for the treatment and prevention of systemic fungal infections. our second ... read more
cidara is a biotechnology company focused on the discovery, development, and commercialization of novel anti-infectives for the treatment of diseases that are inadequately addressed by current standard of care therapies. our first product candidate is cd101 iv, a potential once-weekly intravenous therapy being developed for the treatment and prevention of systemic fungal infections. our second product candidate, cd101 topical, is a topical formulation of cd101, the first topical application of the enchinocandin class of anti-fungals, for the treatment of vulvovaginal candidiasis, or vvc. in addition, we have developed a proprietary immunotherapy technology platform, cloudbreak™, which we use to create compounds designed to direct a patient’s immune cells to attack and eliminate pathogens that cause infectious disease. we are developing our first cloudbreak development candidate, c001, for the treatment of invasive aspergillosis. read less
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Stein Jeffrey | President & CEO | Mar 11, 2024 | Option Exercise | $0.69 | 56,692 | 39,117 | 1,153,693 | Mar 12, 2024, 09:48 PM |
Tari Leslie | CHIEF SCIENTIFIC OFFICER | Mar 11, 2024 | Sale | $0.67 | 21,029 | 14,085 | 258,681 | Mar 12, 2024, 09:48 PM |
Sandison Taylor | Chief Medical Officer | Mar 11, 2024 | Sale | $0.67 | 20,662 | 13,839 | 347,095 | Mar 12, 2024, 09:47 PM |
Ward Shane | COO & CLO | Mar 11, 2024 | Sale | $0.67 | 20,473 | 13,713 | 198,770 | Mar 12, 2024, 09:46 PM |
Shah Preetam | CFO & CBO | Mar 11, 2024 | Sale | $0.67 | 18,931 | 12,680 | 227,210 | Mar 12, 2024, 09:45 PM |
Tari Leslie | CHIEF SCIENTIFIC OFFICER | Sep 11, 2023 | Sale | $0.95 | 18,469 | 17,509 | 275,710 | Sep 13, 2023, 04:24 PM |
Sandison Taylor | Chief Medical Officer | Sep 11, 2023 | Sale | $0.95 | 18,793 | 17,810 | 363,757 | Sep 13, 2023, 04:22 PM |
Tari Leslie | CHIEF SCIENTIFIC OFFICER | Aug 14, 2023 | Buy | $0.97 | 10,000 | 9,700 | 294,179 | Aug 14, 2023, 07:40 PM |
Stein Jeffrey | President & CEO | Aug 08, 2023 | Buy | $0.96 | 50,000 | 47,885 | 331,602 | Aug 08, 2023, 06:04 PM |
Stein Jeffrey | President & CEO | Mar 27, 2023 | Buy | $1.04 | 50,000 | 51,855 | 281,602 | Mar 27, 2023, 07:03 PM |
Ward Shane | COO & CLO | Mar 13, 2023 | Sale | $1.53 | 4,329 | 6,623 | 84,576 | Mar 13, 2023, 09:21 PM |
Tari Leslie | CHIEF SCIENTIFIC OFFICER | Mar 13, 2023 | Sale | $1.53 | 7,562 | 11,570 | 190,179 | Mar 13, 2023, 09:21 PM |
Shah Preetam | CFO & CBO | Mar 13, 2023 | Sale | $1.53 | 6,648 | 10,171 | 148,141 | Mar 13, 2023, 09:20 PM |
Sandison Taylor | Chief Medical Officer | Mar 13, 2023 | Sale | $1.53 | 7,203 | 11,021 | 288,550 | Mar 13, 2023, 09:19 PM |
Tari Leslie | CHIEF SCIENTIFIC OFFICER | Jan 12, 2023 | Sale | $1.20 | 11,814 | 14,177 | 1,484 | Jan 27, 2023, 04:33 PM |
Shah Preetam | CFO & CBO | Sep 19, 2022 | Sale | $0.77 | 15,642 | 12,035 | 150,789 | Sep 19, 2022, 08:28 PM |
Sandison Taylor | Chief Medical Officer | Sep 12, 2022 | Sale | $0.68 | 18,478 | 12,656 | 291,753 | Sep 13, 2022, 06:51 PM |
Tari Leslie | CHIEF SCIENTIFIC OFFICER | Sep 12, 2022 | Sale | $0.68 | 18,159 | 12,437 | 193,741 | Sep 13, 2022, 06:48 PM |
Daruwala Paul | Chief Operating Officer | Sep 12, 2022 | Sale | $0.68 | 16,199 | 11,095 | 221,099 | Sep 13, 2022, 06:40 PM |
Shah Preetam | CFO & CBO | Mar 31, 2022 | Option Exercise | $0.83 | 24,820 | 20,601 | 112,431 | Apr 04, 2022, 05:21 PM |
Ward Shane | CHIEF LEGAL OFFICER | Mar 31, 2022 | Option Exercise | $0.83 | 23,122 | 19,191 | 80,905 | Apr 04, 2022, 05:12 PM |
Stein Jeffrey | President & CEO | Mar 31, 2022 | Option Exercise | $0.83 | 140,985 | 117,018 | 922,635 | Apr 04, 2022, 05:09 PM |
Johnson Brady | Vice President, Finance | Mar 21, 2022 | Sale | $0.81 | 654 | 530 | 49,366 | Mar 23, 2022, 06:11 PM |
Johnson Brady | Vice President, Finance | Mar 11, 2022 | Sale | $0.71 | 945 | 671 | 50,020 | Mar 11, 2022, 08:29 PM |
Daruwala Paul | Chief Operating Officer | Jan 05, 2022 | Sale | $1.25 | 5,133 | 6,416 | 187,298 | Jan 07, 2022, 08:26 PM |
Johnson Brady | Vice President, Finance | Jan 05, 2022 | Sale | $1.25 | 416 | 520 | 50,965 | Jan 07, 2022, 08:23 PM |
Tari Leslie | Chief Scientific Officer | Jan 05, 2022 | Sale | $1.25 | 1,252 | 1,565 | 155,400 | Jan 07, 2022, 08:20 PM |
Stein Jeffrey | President & CEO | Nov 12, 2021 | Buy | $1.59 | 50,000 | 79,530 | 465,878 | Nov 15, 2021, 06:41 PM |
Shah Preetam | CFO & CBO | Nov 12, 2021 | Buy | $1.54 | 20,000 | 30,800 | 20,000 | Nov 15, 2021, 06:38 PM |
Franson Timothy R | Director | Sep 13, 2021 | Buy | $2.12 | 7,000 | 14,823 | 11,000 | Sep 14, 2021, 07:59 PM |
Stein Jeffrey | President & CEO | Aug 19, 2021 | Buy | $1.79 | 10,000 | 17,871 | 415,878 | Aug 19, 2021, 04:24 PM |
Stein Jeffrey | President & CEO | Aug 18, 2021 | Buy | $1.72 | 40,000 | 68,884 | 405,878 | Aug 19, 2021, 04:24 PM |
Daruwala Paul | Chief Operating Officer | Jan 05, 2021 | Sale | $2.06 | 2,868 | 5,908 | 49,724 | Apr 05, 2021, 06:17 PM |
Daruwala Paul | Chief Operating Officer | Apr 01, 2021 | Sale | $2.66 | 593 | 1,577 | 50,531 | Apr 05, 2021, 06:17 PM |
Oien Jessica | General Counsel & Secretary | Apr 01, 2021 | Sale | $2.66 | 1,177 | 3,131 | 7,764 | Apr 05, 2021, 05:35 PM |
Oien Jessica | General Counsel & Secretary | Jan 05, 2021 | Sale | $2.06 | 824 | 1,697 | 6,141 | Apr 05, 2021, 05:35 PM |
Stein Jeffrey | President & CEO | Nov 10, 2020 | Buy | $2.00 | 50,000 | 100,015 | 347,878 | Nov 12, 2020, 06:00 AM |
Levine James E. | Chief Financial Officer | Nov 10, 2020 | Buy | $2.01 | 50,000 | 100,720 | 50,000 | Nov 12, 2020, 06:00 AM |
Abdollahian Neil | Chief Business Officer | Jan 03, 2020 | Sale | $3.42 | 940 | 3,215 | 50,308 | Jun 25, 2020, 08:03 PM |
Daruwala Paul | Chief Operating Officer | Jan 03, 2020 | Sale | $3.42 | 940 | 3,215 | 52,592 | Jun 25, 2020, 08:01 PM |
Levine James E. | Chief Financial Officer | Sep 24, 2019 | Buy | $1.91 | 30,000 | 57,240 | 30,000 | Mar 23, 2020, 07:12 PM |
Sandison Taylor | Chief Medical Officer | Feb 10, 2020 | Option Exercise | $2.51 | 6,115 | 15,349 | 73,331 | Feb 11, 2020, 06:46 PM |
Sandison Taylor | Chief Medical Officer | Feb 07, 2010 | Option Exercise | $2.51 | 4,594 | 11,531 | 67,216 | Feb 11, 2020, 06:46 PM |
Stein Jeffrey | President & CEO | Jan 29, 2020 | Option Exercise | $2.51 | 32,283 | 81,030 | 257,902 | Jan 30, 2020, 08:50 PM |
Stein Jeffrey | President & CEO | Jan 29, 2020 | Option Exercise | $2.51 | 7,558 | 18,971 | 293,878 | Jan 30, 2020, 08:50 PM |
Levine James E. | Chief Financial Officer | Jan 28, 2020 | Option Exercise | $2.51 | 6,891 | 17,296 | 211,891 | Jan 30, 2020, 08:49 PM |
Oien Jessica | General Counsel & Secretary | Jan 02, 2020 | Sale | $3.86 | 834 | 3,219 | 6,965 | Jan 06, 2020, 05:28 PM |
Abdollahian Neil | Chief Business Officer | Jan 03, 2020 | Sale | $3.42 | 2,340 | 8,003 | 51,248 | Jan 06, 2020, 05:27 PM |
Daruwala Paul | Chief Operating Officer | Jan 03, 2020 | Sale | $3.42 | 2,340 | 8,003 | 53,532 | Jan 06, 2020, 05:26 PM |
Daruwala Paul | Chief Operating Officer | Oct 02, 2019 | Sale | $1.88 | 3,295 | 6,195 | 55,872 | Oct 03, 2019, 09:15 PM |
Abdollahian Neil | Chief Business Officer | Oct 01, 2019 | Sale | $1.98 | 7,284 | 14,422 | 49,588 | Oct 03, 2019, 09:13 PM |
Oien Jessica | General Counsel & Secretary | Sep 27, 2019 | Sale | $1.86 | 1,001 | 1,862 | 7,799 | Oct 01, 2019, 05:07 PM |
Stein Jeffrey | President & CEO | Sep 24, 2019 | Buy | $1.91 | 52,500 | 100,102 | 225,619 | Sep 26, 2019, 09:23 PM |
Levine James E. | Chief Financial Officer | Sep 24, 2019 | Buy | $1.91 | 30,000 | 57,240 | 205,000 | Sep 26, 2019, 09:17 PM |
Abdollahian Neil | Chief Business Officer | Mar 08, 2019 | Sale | $2.44 | 2,300 | 5,612 | 30,472 | Mar 08, 2019, 07:30 PM |
Daruwala Paul | Chief Operating Officer | Mar 07, 2019 | Sale | $2.55 | 2,240 | 5,714 | 49,567 | Mar 08, 2019, 07:29 PM |
Stein Jeffrey | President & CEO | May 23, 2018 | Buy | $4.70 | 212,766 | 1,000,000 | 268,320 | May 24, 2018, 05:16 PM |
BIOTECH TARGET N V | 10% Owner | Nov 15, 2017 | Buy | $7.57 | 60,000 | 453,966 | 2,295,272 | Nov 16, 2017, 12:19 PM |
Stein Jeffrey | President & CEO | Sep 12, 2017 | Buy | $6.79 | 7,350 | 49,906 | 51,851 | Sep 12, 2017, 05:49 PM |
Sandison Taylor | Chief Medical Officer | Jun 06, 2017 | Buy | $5.90 | 656 | 3,870 | 6,351 | Jun 08, 2017, 04:40 PM |
Sandison Taylor | Chief Medical Officer | Jun 07, 2017 | Buy | $5.90 | 19,344 | 114,130 | 25,695 | Jun 08, 2017, 04:40 PM |
Stein Jeffrey | President & CEO | Jun 05, 2017 | Buy | $5.95 | 15,000 | 89,211 | 44,501 | Jun 07, 2017, 04:45 PM |
Stein Jeffrey | President & CEO | Mar 31, 2017 | Buy | $7.75 | 12,900 | 99,975 | 27,196 | Apr 04, 2017, 04:33 PM |
Forrest Kevin | COO & CFO | May 20, 2016 | Buy | $11.53 | 4,356 | 50,225 | 58,253 | May 23, 2016, 04:34 PM |
Stein Jeffrey | President & CEO | May 20, 2016 | Buy | $11.51 | 4,310 | 49,608 | 203,697 | May 23, 2016, 04:32 PM |
Stein Jeffrey | President & CEO | Nov 25, 2015 | Buy | $15.60 | 1,300 | 20,280 | 6,700 | Nov 27, 2015, 05:33 PM |
Stein Jeffrey | President & CEO | Nov 24, 2015 | Buy | $14.97 | 5,400 | 80,838 | 5,400 | Nov 27, 2015, 05:33 PM |
Forrest Kevin | COO & CFO | Nov 23, 2015 | Buy | $14.23 | 7,087 | 100,848 | 51,719 | Nov 23, 2015, 07:18 PM |
Heron Patrick J | Director | Apr 20, 2015 | Buy | $16.00 | 200,000 | 3,200,000 | 155,645 | Apr 22, 2015, 02:49 PM |
Kjellson Nina S | Director | Apr 20, 2015 | Buy | $16.00 | 200,000 | 3,200,000 | 200,000 | Apr 22, 2015, 02:45 PM |
Stein Jeffrey | President & CEO | Apr 20, 2015 | Buy | $16.00 | 420 | 6,720 | 420 | Apr 21, 2015, 03:35 PM |
PEREZ ROBERT J | Director | Apr 20, 2015 | Buy | $16.00 | 5,000 | 80,000 | 5,000 | Apr 21, 2015, 03:32 PM |
Franson Timothy R | Director | Apr 20, 2015 | Buy | $16.00 | 4,000 | 64,000 | 4,000 | Apr 21, 2015, 03:31 PM |
BURGESS DANIEL D | Director | Apr 20, 2015 | Buy | $16.00 | 3,000 | 48,000 | 3,000 | Apr 21, 2015, 03:29 PM |
Owner | Relationship | Date | Value($) |
Stein Jeffrey | President & CEO | 03/11/2024 | 39,117 |
Tari Leslie | CHIEF SCIENTIFIC OFFICER | 03/11/2024 | 14,085 |
Sandison Taylor | Chief Medical Officer | 03/11/2024 | 13,839 |
Ward Shane | COO & CLO | 03/11/2024 | 13,713 |
Shah Preetam | CFO & CBO | 03/11/2024 | 12,680 |
Tari Leslie | CHIEF SCIENTIFIC OFFICER | 09/11/2023 | 17,509 |
Sandison Taylor | Chief Medical Officer | 09/11/2023 | 17,810 |
Tari Leslie | CHIEF SCIENTIFIC OFFICER | 08/14/2023 | 9,700 |
Stein Jeffrey | President & CEO | 08/08/2023 | 47,885 |
Stein Jeffrey | President & CEO | 03/27/2023 | 51,855 |
Ward Shane | COO & CLO | 03/13/2023 | 6,623 |
Tari Leslie | CHIEF SCIENTIFIC OFFICER | 03/13/2023 | 11,570 |
Shah Preetam | CFO & CBO | 03/13/2023 | 10,171 |
Sandison Taylor | Chief Medical Officer | 03/13/2023 | 11,021 |
Tari Leslie | CHIEF SCIENTIFIC OFFICER | 01/12/2023 | 14,177 |
Shah Preetam | CFO & CBO | 09/19/2022 | 12,035 |
Sandison Taylor | Chief Medical Officer | 09/12/2022 | 12,656 |
Tari Leslie | CHIEF SCIENTIFIC OFFICER | 09/12/2022 | 12,437 |
Daruwala Paul | Chief Operating Officer | 09/12/2022 | 11,095 |
Shah Preetam | CFO & CBO | 03/31/2022 | 20,601 |
Ward Shane | CHIEF LEGAL OFFICER | 03/31/2022 | 19,191 |
Stein Jeffrey | President & CEO | 03/31/2022 | 117,018 |
Johnson Brady | Vice President, Finance | 03/21/2022 | 530 |
Johnson Brady | Vice President, Finance | 03/11/2022 | 671 |
Daruwala Paul | Chief Operating Officer | 01/05/2022 | 6,416 |
Johnson Brady | Vice President, Finance | 01/05/2022 | 520 |
Tari Leslie | Chief Scientific Officer | 01/05/2022 | 1,565 |
Stein Jeffrey | President & CEO | 11/12/2021 | 79,530 |
Shah Preetam | CFO & CBO | 11/12/2021 | 30,800 |
Franson Timothy R | Director | 09/13/2021 | 14,823 |
Stein Jeffrey | President & CEO | 08/19/2021 | 17,871 |
Stein Jeffrey | President & CEO | 08/18/2021 | 68,884 |
Daruwala Paul | Chief Operating Officer | 01/05/2021 | 5,908 |
Daruwala Paul | Chief Operating Officer | 04/01/2021 | 1,577 |
Oien Jessica | General Counsel & Secretary | 04/01/2021 | 3,131 |
Oien Jessica | General Counsel & Secretary | 01/05/2021 | 1,697 |
Stein Jeffrey | President & CEO | 11/10/2020 | 100,015 |
Levine James E. | Chief Financial Officer | 11/10/2020 | 100,720 |
Abdollahian Neil | Chief Business Officer | 01/03/2020 | 3,215 |
Daruwala Paul | Chief Operating Officer | 01/03/2020 | 3,215 |
Levine James E. | Chief Financial Officer | 09/24/2019 | 57,240 |
Sandison Taylor | Chief Medical Officer | 02/10/2020 | 15,349 |
Sandison Taylor | Chief Medical Officer | 02/07/2010 | 11,531 |
Stein Jeffrey | President & CEO | 01/29/2020 | 81,030 |
Stein Jeffrey | President & CEO | 01/29/2020 | 18,971 |
Levine James E. | Chief Financial Officer | 01/28/2020 | 17,296 |
Oien Jessica | General Counsel & Secretary | 01/02/2020 | 3,219 |
Abdollahian Neil | Chief Business Officer | 01/03/2020 | 8,003 |
Daruwala Paul | Chief Operating Officer | 01/03/2020 | 8,003 |
Daruwala Paul | Chief Operating Officer | 10/02/2019 | 6,195 |
Abdollahian Neil | Chief Business Officer | 10/01/2019 | 14,422 |
Oien Jessica | General Counsel & Secretary | 09/27/2019 | 1,862 |
Stein Jeffrey | President & CEO | 09/24/2019 | 100,102 |
Levine James E. | Chief Financial Officer | 09/24/2019 | 57,240 |
Abdollahian Neil | Chief Business Officer | 03/08/2019 | 5,612 |
Daruwala Paul | Chief Operating Officer | 03/07/2019 | 5,714 |
Stein Jeffrey | President & CEO | 05/23/2018 | 1,000,000 |
BIOTECH TARGET N V | 10% Owner | 11/15/2017 | 453,966 |
Stein Jeffrey | President & CEO | 09/12/2017 | 49,906 |
Sandison Taylor | Chief Medical Officer | 06/06/2017 | 3,870 |
Sandison Taylor | Chief Medical Officer | 06/07/2017 | 114,130 |
Stein Jeffrey | President & CEO | 06/05/2017 | 89,211 |
Stein Jeffrey | President & CEO | 03/31/2017 | 99,975 |
Forrest Kevin | COO & CFO | 05/20/2016 | 50,225 |
Stein Jeffrey | President & CEO | 05/20/2016 | 49,608 |
Stein Jeffrey | President & CEO | 11/25/2015 | 20,280 |
Stein Jeffrey | President & CEO | 11/24/2015 | 80,838 |
Forrest Kevin | COO & CFO | 11/23/2015 | 100,848 |
Heron Patrick J | Director | 04/20/2015 | 3,200,000 |
Kjellson Nina S | Director | 04/20/2015 | 3,200,000 |
Stein Jeffrey | President & CEO | 04/20/2015 | 6,720 |
PEREZ ROBERT J | Director | 04/20/2015 | 80,000 |
Franson Timothy R | Director | 04/20/2015 | 64,000 |
BURGESS DANIEL D | Director | 04/20/2015 | 48,000 |
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
RENAISSANCE TECHNOLOGIES LLC | 1,802,173 | 0.00221% | 12.66% | Other |
BLACKROCK INC. | 938,161 | 0.00002% | -0.54% | Other |
GEODE CAPITAL MANAGEMENT, LLC | 805,871 | 0.00007% | No change | Other |
Period of Report: 09/30/2023
10-K/10-Q Filings: View